The Board of Directors of Corcept Therapeutics Incorporated has authorized a buyback plan on January 8, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.88 USD | +2.40% | +3.83% | -26.48% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.48% | 2.42B | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- CORT Stock
- News Corcept Therapeutics Incorporated
- Corcept Therapeutics Incorporated authorizes a Buyback Plan.